| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695265 | Gynecologic Oncology | 2017 | 7 Pages |
Abstract
Our results demonstrate that trabectedin has an interesting efficacy as a single agent in heavily treated ROC patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jean-Philippe Adam, Feriel Boumedien, Nathalie Letarte, Diane Provencher,